Blog
FDA Approves Leqembi™
On Friday, January 6, the US Food and Drug Administration gave accelerated approval to Leqembi™ (lecanemab – irmb), a drug developed by Eisai in partnership with Biogen, for the treatment of Alzheimer’s disease. The drug [View More]
Embracing Your “Land of Hope and Dreams”
I’ve been a fan of Bruce Springsteen’s music for as long as I can remember. His “stories” have spoken to me in different ways during different periods of my life. Perhaps, that comes from [View More]
Lecanemab Clinical Trial Data
Recently released data from Eisai’s Phase 3 clinical trial of lecanemab shows that the drug slowed the rate of cognitive decline by 27% as compared to the placebo group in an 18-month study of participants [View More]
Ken Zaentz Featured on NJ Morning Show
Watch Alzheimer's New Jersey CEO Ken Zaentz discuss the impact of Alzheimer's on the New Jersey Morning Show
The Gift of Help for Father’s Day
This weekend as we celebrate Father’s Day, I want to share a message with men who find themselves in the role of caregiver – particularly those in The Silent Generation (1925-1945) and The Baby Boomer [View More]
Mother’s Day
Mother’s Day is celebrated in over 46 countries across the globe. It’s a day to honor the unique and important contributions of the person called Mom. Motherhood is not necessarily about biology. It’s about unconditional [View More]